English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Sanofi Us
Press release submission
| May 8, 2018
SANOFI US: Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients
Carol Ostrow
| Oct 7, 2017
Dupixent gains approval as atopic dermatitis treatment in Europe
Nicholas Gueguen
| Jul 23, 2017
Study: Dupixent used with topical corticosteroids improves atopic dermatitis
Nicholas Gueguen
| Jul 1, 2017
FDA OKs Kevzara for moderate to severe rheumatoid arthritis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Robert Hadley
| Apr 15, 2017
Toujeo maker touts drug’s ability to lower blood sugar
Erianne Leatherman
| Apr 5, 2017
Sanofi Genzyme expands Multiple Myeloma Journey Partners program
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
+
Regulatory
Patient Daily News Service
| Dec 15, 2024
Steve Forbes: ‘Unfair’ to allow ‘big insurer-PBMs to pocket big Rx discounts meant for patients’
+
Pharmaceuticals
Patient Daily
| Dec 17, 2024
Lung association warns against combined risks of smoking and radon
Patient Daily reports
| Dec 13, 2024
Unicycive CEO Dr. Gupta: 'I started Unicycive to address the significant challenges in healthcare'
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
Discovery of replication hubs may lead to new antiviral therapies for norovirus
